Systemic α-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 304, Issue 10, 2013, Pages

  Gómez SanMiguel, Ana Belén ^a   Martín, Ana Isabel ^a   Nieto Bona, Maria Paz ^b   Fernández Galaz, Carmen ^a   López Menduiña, María ^a   Villanúa, María Ángeles ^a   López Calderón, Asunción ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Adjuvant induced arthritis; Atrogin 1; Cox 2; Food intake; Il 1 ; Il 10; Muscle specific ringfinger protein 1 1; Proopiomelanocortin; Ubiquitin proteasome system

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; ATROGIN 1; CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 1BETA; MUSCLE RING FINGER 1 PROTEIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTHRITIS; ARTHRITIS INDUCED ANOREXIA; ARTHRITIS INDUCED MUSCLE WASTING; ARTICLE; CACHEXIA; CONTROLLED STUDY; FOOD INTAKE; GASTROCNEMIUS MUSCLE; HYPOTHALAMUS; MALE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; WEIGHT GAIN;

ADJUVANT-INDUCED ARTHRITIS; ATROGIN-1; COX-2; FOOD INTAKE; IL-1Β; IL-10; MUSCLE-SPECIFIC RING-FINGER PROTEIN-1 1; PROOPIOMELANOCORTIN; UBIQUITIN-PROTEASOME SYSTEM;

AGOUTI-RELATED PROTEIN; ALPHA-MSH; ANIMALS; ANOREXIA; ARTHRITIS, EXPERIMENTAL; CACHEXIA; CYCLOOXYGENASE 2; HYPOTHALAMUS; INTERLEUKIN-1BETA; MALE; MUSCULAR ATROPHY; NEUROPEPTIDE Y; RATS; RATS, WISTAR;

EID: 84878625491     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00447.2012     Document Type: Article

References (71)

1. Baracos VE, DeVivo C, Hoyle DH, Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol Endocrinol Metab 268: E996-E1006, 1995.
2. Bitto A, Polito F, Altavilla D, Irrera N, Giuliani D, Ottani A, Minutoli L, Spaccapelo L, Galantucci M, Lodi R, Guzzo G, Guarini S, Squadrito F. Melanocortins protect against multiple organ dysfunction syndrome in mice. Br J Pharmacol 162: 917-928, 2011.
3. Bluthé RM, Castanon N, Pousset F, Bristow A, Ball C, Lestage J, Michaud B, Kelley KW, Dantzer R. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 24: 301-11, 1999.
4. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001.
5. Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte- stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29: 581-602, 2008.
6. Castillero E, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A. IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting. Mol Cell Endocrinol 309: 8-16, 2009.
7. Castillero E, Nieto-Bona MP, Fernández-Galaz C, Martín AI, López- Menduiña M, Granado M, Villanúa MA, López-Calderón A. Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. Am J Physiol Endocrinol Metab 300: E790-E799, 2011.
8. Cao C, Matsumura K, Yamagata K, Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever. Brain Res 733: 263-272, 1996.
9. Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM. The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1: 28-32, 1994.
10. Chang SH, Jung EJ, Lim DG, Park YH, Wee YM, Kim JH, Kim YH, Choi MY, Koo SK, Choi KD, Han DJ, Kim SC. Anti-inflammatory action of alpha-melanocyte stimulating hormone (alpha-MSH) in anti- CD3/CD28-mediated spleen and CD4()CD25(α) T cells and a partial participation of IL-10. Immunol Lett 118: 44-48, 2008.
11. Cheung WW, Kuo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak RH. Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol 18: 2517-2524, 2007.
12. Davis TW, Zweifel BS, O'Neal JM, Heuvelman DM, Abegg AL, Hendrich TO, et al. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting. J Pharmacol Exp Ther 308: 929-934, 2004.
13. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168, 1997.
14. Fan C, Liu X, Shen W, Deckelbaum RJ, Qi K. The regulation of leptin, leptin receptor and pro-opiomelanocortin expression by N-3 PUFAs in diet-induced obese mice is not related to the methylation of their promoters. Nutr Metab 8: 31, 2011.
15. Fong Y, Moldawer LL, Marano M, Wei H, Barber A, Manogue K, Tracey KJ, Kuo G, Fischman DA, Cerami A, Lowry SF. Cachectin/ TNF or IL-1 α induces cachexia with redistribution of body proteins. Am J Physiol Regul Integr Comp Physiol 256: R659-R665, 1989.
16. Francis J, MohanKumar PS, MohanKumar SM, Quadri SK. Systemic administration of lipopolysaccharide increases plasma leptin levels: blockade by soluble interleukin-1 receptor. Endocrine 10: 291-295, 1999.
17. García-Martínez C, Llovera M, Agell N, López-Soriano FJ, Argilés JM,. Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1. Biochem Biophys Res Commun 17: 839-844, 1995.
18. Getting SJ, Kaneva M, Bhadresa Y, Renshaw D, Leoni G, Patel HB, Kerrigan PM, Locke IC. Melanocortin peptide therapy for the treatment of arthritic pathologies. Scientific World J 9: 1394-1414, 2009.
19. Gómez-Ambrosi J, Zabalegui N, Bing C, Tisdale MJ, Trayhurn P, Williams G. Weight loss in tumour-bearing mice is not associated with changes in resistin gene expression in white adipose tissue. Horm Metab Res 34: 674-677, 2002.
20. Gout J, Sarafian D, Mutel E, Vigier M, Rajas F, Mithieux G, Begeot M, Naville D. Metabolic and melanocortin gene expression alterations in male offspring of obese mice. Mol Cell Endocrinol 319: 99-108, 2010.
21. Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 288: E486-E492, 2005.
22. Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. Am J Physiol Endocrinol Metab 289: E1007-E1114, 2005.
23. Granado M, Martín AI, Villanúa MA, López-Calderón A. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation. Am J Physiol Endocrinol Metab 292: E1656-E1665, 2007.
24. Giuliani D, Mioni C, Bazzani C, Zaffe D, Botticelli AR, Capolongo S, Sabba A, Galantucci M, Iannone A, Grieco P, Novellino E, Colombo G, Tomasi A, Catania A, Guarini S. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage. Br J Pharmacol 150: 595-603, 2007.
25. Hataya Y, Akamizu T, Hosoda H, Kanamoto N, Moriyama K, Kangawa K, Takaya K, Nakao K. Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology 144: 5365-5371, 2003.
26. Hitt A, Graves E, McCarthy DO. Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor-bearing mice. Res Nurs Health 28: 56-66, 2005.
27. Hollis JH, Lemus M, Evetts MJ, Oldfield BJ. Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression. Neuropharmacology 58: 730-738, 2010.
28. Hussey HJ, Tisdale MJ. Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model. Int J Cancer 87: 95-100, 2000.
29. Ibañez De Cáceres I, Villanúa MA, Soto L, Martin AI, López-Calderón A. IGF-I and IGF-I-binding proteins in rats with adjuvantinduced arthritis given recombinant human growth hormone. J Endocrinol 165: 537-544, 2000.
30. Jensen PB, Blume N, Mikkelsen JD, Larsen PJ, Jensen HI, Holst JJ, Madsen OD. Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus. J Clin Invest 101: 503-510, 1998.
31. Johnson PM, Vogt SK, Burney MW, Muglia LJ. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. Am J Physiol Endocrinol Metab 282: E650-E656, 2002.
32. Kinzig KP, Hargrave SL, Tao EE. Central and peripheral effects of chronic food restriction and weight restoration in the rat. Am J Physiol Endocrinol Metab 296: E282-E290, 2009.
33. Korner J, Savontaus E, Chua SC Jr, Leibel RL, Wardlaw SL. Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus. J Neuroendocrinol 13: 959-966, 2001.
34. Layé S, Gheusi G, Cremona S, Combe C, Kelley K, Dantzer R, Parnet P. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol 279: R93-R98, 2000.
35. Lee JH, Cha MJ, Choi SH, Hwang SJ, Kim DG, Jahng JW. Neuropeptide Y immunoreactivity and corticotropin-releasing hormone mRNA level are increased in the hypothalamus of mouse bearing a human oral squamous cell carcinoma. Neuropeptides 38: 345-350, 2004.
36. Lira FS, Yamashita AS, Rosa JC, Tavares FL, Caperuto E, Carnevali LC Jr, Pimentel GD, Santos RV, Batista ML Jr, Laviano A, Rossi-Fanelli F, Seelaender M. Hypothalamic inflammation is reversed by endurance training in anorectic-cachectic rats. Nutr Metab 8: 60, 2011.
37. López-Calderón A, Ariznavarreta C, Chen CL. Influence of chronic restraint stress on pro-opiomelanocortin mRNA and beta-endorphin in the rat hypothalamus. J Mol Endocrinol 7: 197-204, 1991.
38. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer 61: 138-141, 1995.
39. Lundholm K, Daneryd P, Korner U, Hyltander A, Bosaeus I. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 24: 505-512, 2004.
40. Markison S, Foster AC, Chen C, Brookhart GB, Hesse A, Hoare SR, Fleck BA, Brown BT, Marks DL. The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist. Endocrinology 146: 2766-2773, 2005.
41. Marks DL, Ling N, Cone RD. Role of the central melanocortin system in cachexia. Cancer Res 61: 1432-1438, 2001.
42. Martín AI, Castillero E, Granado M, López-Menduiña M, Villanúa MA, López-Calderón A. Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis. J Endocrinol 197: 111-119, 2008.
43. Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TE, Perretti M. The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. Am J Pathol 179: 259-269, 2011.
44. Minutoli L, Bitto A, Squadrito F, Irrera N, Rinaldi M, Nicotina PA, Arena S, Magno C, Marini H, Spaccapelo L, Ottani A, Giuliani D, Romeo C, Guarini S, Antonuccio P, Altavilla D. Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway. Endocrinology 152: 3852-3861, 2011.
45. Mrosovsky N, Molony LA, Conn CA, Kluger MJ. Anorexic effects of interleukin 1 in the rat. Am J Physiol Regul Integr Comp Physiol 257: R1315-R1321, 1989.
46. Murphy MT, Richards DB, Lipton JM. Antipyretic potency of centrally administered alpha-melanocyte stimulating hormone. Science 221: 192-193, 1983.
47. Nara-ashizawa N, Tsukada T, Maruyama K, Akiyama Y, Kajimura N, Nagasaki K, Iwanaga T, Yamaguchi K. Hypothalamic appetiteregulating neuropeptide mRNA levels in cachectic nude mice bearing human tumor cells. Metabolism 50: 1213-1219, 2001.
48. Nillni EA. Regulation of prohormone convertases in hypothalamic neurons: implications for prothyrotropin-releasing hormone and proopiomelanocortin. Endocrinology 148: 4191-4200, 2007.
49. Perello M, Stuart RC, Nillni EA. Differential effects of fasting and leptin on proopiomelanocortin peptides in the arcuate nucleus and in the nucleus of the solitary tract. Am J Physiol Endocrinol Metab 292: E1348-E1357, 2007.
50. Plata-Salamán CR, Oomura Y, Kai Y. Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res 448: 106-114, 1988.
51. Plata-Salamán CR, Ilyin SE, Gayle D. Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am J Physiol Regul Integr Comp Physiol 275: R566-R573, 1998.
52. Raap U, Brzoska T, Sohl S, Path G, Emmel J, Herz U, Braun A, Luger T, Renz H. Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol 171: 353-359, 2003.
53. Rajora N, Boccoli G, Catania A, Lipton JM. alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18: 381-385, 1997.
54. Rajora N, Boccoli G, Burns D, Sharma S, Catania AP, Lipton JM. alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J Neurosci 17: 2181-2186, 1997.
55. Redondo P, García-Foncillas J, Okroujnov I, Bandrés E. α-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res 290: 425-428, 1998.
56. Romero FI, Martínez-Calatrava MJ, Sánchez-Pernaute O, Gualillo O, Largo R, Herrero-Beaumont G. Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits. Br J Pharmacol 161: 1012-1022, 2010.
57. Rorato R, Menezes AM, Giusti-Paiva A, de Castro M, Antunes- Rodrigues J, Elias LL. Prostaglandin mediates endotoxaemia-induced hypophagia by activation of pro-opiomelanocortin and corticotrophinreleasing factor neurons in rats. Exp Physiol 94: 371-379, 2009.
58. Sanchez VC, Goldstein J, Stuart RC, Hovanesian V, Huo L, Munzberg H, Friedman TC, Bjorbaek C, Nillni EA. Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone. J Clin Invest 114: 357-369, 2004.
59. Scarlett JM, Jobst EE, Enriori PJ, Bowe DD, Batra AK, Grant WF, Cowley MA, Marks DL. Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology 148: 4217-4225, 2007.
60. Scarlett JM, Bowe DD, Zhu X, Batra AK, Grant WF, Marks DL. Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure. J Endocrinol 206: 121-130, 2010.
61. Sergeyev V, Broberger C, Hökfelt T. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res Mol 90: 93-100, 2001.
62. Shimizu H, Inoue K, Mori M. The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol 93: 1-9, 2007.
63. Spaccapelo L, Bitto A, Galantucci M, Ottani A, Irrera N, Minutoli L, Altavilla D, Novellino E, Grieco P, Zaffe D, Squadrito F, Giuliani D, Guarini S. Melanocortin MC4 receptor agonists counteract late inflammatory and apoptotic responses and improve neuronal functionality after cerebral ischemia. Eur J Pharmacol 670: 479-486, 2011.
64. Stofkova A, Haluzik M, Zelezna B, Kiss A, Skurlova M, Lacinova Z, Jurcovicova J. Enhanced expressions of mRNA for neuropeptide Y and interleukin 1 beta in hypothalamic arcuate nuclei during adjuvant arthritisinduced anorexia in Lewis rats. Neuroimmunomodulation 16: 377-384, 2009.
65. Stofkova A, Zelezna B, Romzova M, Ulicna O, Kiss A, Skurlova M, Jurcovicova J. Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats. Mediators Inflamm pii: 398026, doi:10.1155/2010/398026, 2010.
66. Suzuki H, Hashimoto H, Kawasaki M, Watanabe M, Otsubo H, Ishikura T, Fujihara H, Ohnishi H, Onuma E, Yamada-Okabe H, Takuwa Y, Ogata E, Nakamura T, Ueta Y. Similar changes of hypothalamic feeding-regulating peptides mRNAs and plasma leptin levels in PTHrP-, LIF-secreting tumors-induced cachectic rats and adjuvant arthritic rats. Int J Cancer 128: 2215-2223, 2011.
67. Taherzadeh S, Sharma S, Chhajlani V, Gantz I, Rajora N, Demitri MT, Kelly L, Zhao H, Ichiyama T, Catania A, Lipton JM. alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol Regul Integr Comp Physiol 276: R1289-R1294, 1999.
68. Taylor AW, Kitaichi N. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy. Brain Behav Immun 22: 639-646, 2008.
69. Tiao G, Lieberman M, Fischer JE, Hasselgren PO. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am J Physiol Regul Integr Comp Physiol 272: R849-R856, 1997.
70. Valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 18: 158-168, 2008.
71. Vulliémoz NR, Xiao E, Xia-Zhang L, Ferin M, Wardlaw SL. Melanocortin modulation of inflammatory cytokine and neuroendocrine responses to endotoxin in the monkey. Endocrinology 147: 1878-1883, 2006